Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Patient Safety Goals for U.S. Labs Detailed for 2009

By Labmedica staff writers
Posted on 24 Jun 2008
A 2009 update of a U.S. More...
national patient safety goals report and related requirements for accredited laboratories, promote specific improvements in patient safety by providing healthcare organizations with proven solutions to persistent patient safety problems.

The Joint Commission (Oakbrook Terrace, IL, USA) announced the modification of The National Patient Safety Goals, which is overseen by the Sentinel Event Advisory Group, a panel that includes patient safety experts, nurses, physicians, pharmacists, and risk managers, who have hands-on experience in addressing patient safety issues in hospitals and other healthcare settings. The goals apply to the more than 15,000 Joint Commission-accredited and -certified health care organizations and programs in the United States.

The Joint Commission also accredits health plans, integrated delivery networks, and other managed care entities. In addition, it provides certification of disease-specific care programs, primary stroke centers, and health care staffing services. An independent, not-for-profit organization, The Joint Commission is the nation's oldest and largest standards setting and accrediting body in health care.

The guidelines include emphasis on correct identification of the patient, especially before invasive procedures; verification that the patient correctly receives all test results; communication between caregivers is improved; hand hygiene guidelines are monitored; and that the patient takes an active interest in his/her own care.

"The 2009 National Patient Safety Goals represent ongoing opportunities for improvement that can immediately benefit patients,” said Mark R. Chassin, M.D., M.P.P., M.P.H., president, The Joint Commission. "By taking action to consistently meet the Goals, health care organizations can substantially improve patient safety in America.”

The Joint Commission seeks to continuously improve the safety and quality of care provided to the public through the provision of healthcare accreditation and related services that support performance improvement in healthcare organizations. The Joint Commission evaluates and accredits more than 15,000 healthcare organizations and programs in the United States, including more than 8,000 hospitals and home care organizations, and more than 6,300 other healthcare organizations that provide long-term care, assisted living, behavioral healthcare, laboratory, and ambulatory care services


Related Links:
The Joint Commission

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.